Navigation Links
Northwest Bio to Present at Society of Neuro-Oncology Annual Meeting
Date:11/15/2011

Phase I trials in multiple other cancers.  The Company has also conducted a Phase I/II trial with DCVax for recurrent metastatic ovarian cancer.  For further information about clinical sites and about the Company, please visit the Company's web site at www.nwbio.com.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients with GBM using DCVax and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capital, risks related to the Company's ability to enroll patients in its clinical trials and complete the trials on a timely basis, the uncertainty of the clinical trials process, uncertainties about the timely performance of third parties, and whether the Company's products will demonstrate safety and efficacy.  Additional information on these and other factors, including Risk Factors, which could affect the Company's results, is included in its Securities and Exchange Commission ("SEC") filings.  Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement.  You should not place undue reliance on any forward-looking statements.  The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as r
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
2. Northwestern Memorial Transplant Program Initiates New Study
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
5. Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
6. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
7. New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorials Bluhm Cardiovascular Institute
8. Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
9. Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond
10. Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study
11. Northwestern Memorial Maintains Top Status in Nursing Hospital Renewed for Nurse Magnet®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... India , September 4, 2015 ... 2015 Market Research Report is a professional and ... global Surgical Gown industry with a focus on ... take 2-3 working days once an order is ... market spread across 150 pages, analyzing and profiling ...
(Date:9/4/2015)... PLAINFIELD, N.J. , Sept. 4, 2015 /PRNewswire/ ... pleased to announce five recipients of its first-ever ... Realize Innovation, Vision and Empowerment), designed to aid ... Duchenne muscular dystrophy (DMD) community. The announcement is ... the international World Duchenne Awareness Day on Monday, ...
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: AGN ... Brent Saunders , CEO and President of Allergan, will provide ... Morgan Stanley Global Healthcare Conference 2015 in New ... The presentation will take place on ... the Grand Hyatt New York, 109 East 42nd Street, ...
Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
... , ARDEE, Ireland, Dec. 11 As Warner ... its acquisition of the global branded prescription pharmaceuticals business ... 30, 2009 (the "PGP Acquisition"), constituted a change of ... "Marketing Agreement") between a P&G subsidiary acquired by Warner ...
... , LONDON and PHILADELPHIA, Dec. 11 ... breast cancer experienced a median survival of 14 months when ... (trastuzumab). The results of the Phase III study in HER2-positive ... San Antonio Breast Cancer Symposium, held in San Antonio, Texas ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... elderly Americans currently being cared for in nursing homes and assisted living facilities are ... discussed a personal story in which her father was at one point close to ...
(Date:9/4/2015)... Los Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... recent report in the Journal of the American Dental Association presented data showing that ... procedures. By comparing a group of pregnant women that had undergone local anesthesia with ...
(Date:9/4/2015)... ... 04, 2015 , ... With TransCel from Pixel Film Studios users can simulate ... X. With TransCel users have full control over camera position and angle within 3D ... color, inner color, text, and more. With TransCel the possibilities are endless. , Users ...
(Date:9/4/2015)... San Diego, California (PRWEB) , ... September 04, 2015 , ... ... affiliates on behalf of Tanya De La Paz. , Schmidt National Law Group, ... for the Northern District of California against Bayer Corp., Bayer Essure, Inc., and other ...
(Date:9/4/2015)... ... 2015 , ... IVF New England, one of the largest and most successful ... in Manchester for women who wish to learn more about their fertility and egg ... lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , This hip, casual ...
Breaking Medicine News(10 mins):Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2
... Healthcare consumers have role to play in preventing, recovering from ... ... take several,steps to prevent the theft of their medical identity and ... medical,identity theft, according to a new practice brief, "Mitigating Medical,Identity Theft," ...
... BRUNSWICK, N.J., July 8 Johnson & Johnson,will ... 8:30 a.m. (Eastern,Time) on Tuesday, July 15, 2008, ... and Chief Financial Officer, and Louise,Mehrotra, Vice President, ... and other interested parties may access the broadcast ...
... burden and amount of suffering associated with mental ... health care systems in Europe today. This challenge ... of mental disorders. Important factors are their persistent ... socioeconomic changes currently taking place, and, finally, the ...
... think about what you eat, study finds, , , TUESDAY, July ... with a food diary can double your weight loss, a ... has been around a long time, this latest research offers ... co-author Dr. Victor J. Stevens, a senior investigator at Kaiser ...
... 8 Michael E. Kerr, MD,Director of the Bowen ... in private practice, will address the topic of autism ... one of the most widely,discussed and intensively researched clinical ... a dramatic increase in the,number of children diagnosed to ...
... Home Medical,Equipment, Inc. (OTC: SHOM) announced today that its ... the second quarter of 2008,compared to the first quarter ... stated, "We have focused a significant portion of our ... Medical Staffing. We are,very excited to see that our ...
Cached Medicine News:Health News:Mitigating Medical Identity Theft: AHIMA Journal Provides Patient Tools to Secure Health Information 2Health News:Mitigating Medical Identity Theft: AHIMA Journal Provides Patient Tools to Secure Health Information 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 2Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 4Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 5Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 6Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 7Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 8Health News:Keep a Food Diary, Lose Twice as Much Weight 2Health News:Southern Home Medical Reports Its Encore Medical Staffing Division Increases Revenues by 63% 2
... the rapid, qualitative detection of Group A ... The kit is,self-contained and features all the ... 50 tests including the throat swabs,and a ... rapid, qualitative detection of Group A Streptococcal ...
... Finesse ME+ is designed to meet the ... laboratories by being one of the safest, ... Excellent for routine wax sections and specialized ... provides high quality sections without the the ...
The Shandon Cryotome SME Cryostat model is a sophisticated, top of the line cryostat that combines automated electronic advance and hands-free sectioning with fully independent specimen temperature c...
The Shandon Linistain GLX Linear Stainer is an economical mid-size linear stainer featuring 28 staining stations and a heater/dryer with fume control by a charcoal filter....
Medicine Products: